Published in J Bone Miner Metab on January 01, 2004
Paget disease of the bone: does it exist in Saudi Arabia? Ann Saudi Med (2011) 1.43
Guidelines for diagnosis and management of Paget's disease of bone in Japan. J Bone Miner Metab (2006) 1.04
New knowledge on critical osteoclast formation and activation pathways from study of rare genetic diseases of osteoclasts: focus on the RANK/RANKL axis. Osteoporos Int (2010) 0.94
Signal peptide mutations in RANK prevent downstream activation of NF-κB. J Bone Miner Res (2011) 0.83
The Use of Patient-Specific Induced Pluripotent Stem Cells (iPSCs) to Identify Osteoclast Defects in Rare Genetic Bone Disorders. J Clin Med (2014) 0.76
A randomized trial of vertebroplasty for osteoporotic spinal fractures. N Engl J Med (2009) 10.06
SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet (2008) 5.93
Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet (2012) 5.48
Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nat Genet (2009) 5.32
Identification of new susceptibility loci for osteoarthritis (arcOGEN): a genome-wide association study. Lancet (2012) 3.48
Collaborative meta-analysis: associations of 150 candidate genes with osteoporosis and osteoporotic fracture. Ann Intern Med (2009) 2.80
The association between common vitamin D receptor gene variations and osteoporosis: a participant-level meta-analysis. Ann Intern Med (2006) 2.74
Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis. JAMA (2008) 2.52
Generation Scotland: the Scottish Family Health Study; a new resource for researching genes and heritability. BMC Med Genet (2006) 2.25
Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes. JAMA (2004) 2.20
An integrated approach to consumer representation and involvement in a multicentre randomized controlled trial. Clin Trials (2005) 2.07
Meta-analysis of genome-wide association studies confirms a susceptibility locus for knee osteoarthritis on chromosome 7q22. Ann Rheum Dis (2010) 1.75
FGF-23 in patients with end-stage renal disease on hemodialysis. Kidney Int (2004) 1.74
Randomized trial of intensive bisphosphonate treatment versus symptomatic management in Paget's disease of bone. J Bone Miner Res (2010) 1.73
Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget's disease. Hum Mol Genet (2002) 1.72
Ubiquitin recognition by the ubiquitin-associated domain of p62 involves a novel conformational switch. J Biol Chem (2007) 1.68
Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro. Calcif Tissue Int (2008) 1.62
A variant in MCF2L is associated with osteoarthritis. Am J Hum Genet (2011) 1.60
Assessment of gene-by-sex interaction effect on bone mineral density. J Bone Miner Res (2012) 1.58
Genome-wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget's disease of bone. Nat Genet (2010) 1.58
Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors. Nat Med (2005) 1.56
Association of STAT4 with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in the Japanese population. Arthritis Rheum (2008) 1.51
Incidence of lumbar spondylolysis in the general population in Japan based on multidetector computed tomography scans from two thousand subjects. Spine (Phila Pa 1976) (2009) 1.46
ER stress-mediated apoptosis in a new mouse model of osteogenesis imperfecta. PLoS Genet (2008) 1.37
Athletes with unilateral spondylolysis are at risk of stress fracture at the contralateral pedicle and pars interarticularis: a clinical and biomechanical study. Am J Sports Med (2005) 1.36
Primary hyperparathyroidism with multiple osteosclerotic lesions of the calvarium. J Bone Miner Res (2003) 1.35
Guidelines for the use of biochemical markers of bone turnover in osteoporosis (2004). J Bone Miner Metab (2005) 1.33
Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density and fracture risk in women: a meta-analysis. J Bone Miner Res (2002) 1.29
Ubiquitin ligase Cbl-b is a negative regulator for insulin-like growth factor 1 signaling during muscle atrophy caused by unloading. Mol Cell Biol (2009) 1.27
Genetic and environmental determinants of peak bone mass in young men and women. J Bone Miner Res (2002) 1.27
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity. J Clin Invest (2014) 1.25
Genetics of Paget's disease of bone. Clin Sci (Lond) (2005) 1.25
Single nucleotide polymorphism detection: allelic discrimination using TaqMan. Psychiatr Genet (2002) 1.24
Loss of ubiquitin-binding associated with Paget's disease of bone p62 (SQSTM1) mutations. J Bone Miner Res (2004) 1.23
Polymorphisms in the P450 c17 (17-hydroxylase/17,20-Lyase) and P450 c19 (aromatase) genes: association with serum sex steroid concentrations and bone mineral density in postmenopausal women. J Clin Endocrinol Metab (2004) 1.21
JRAB/MICAL-L2 is a junctional Rab13-binding protein mediating the endocytic recycling of occludin. Mol Biol Cell (2006) 1.20
Genome-wide association identifies three new susceptibility loci for Paget's disease of bone. Nat Genet (2011) 1.20
Pathomechanism of loss of elasticity and hypertrophy of lumbar ligamentum flavum in elderly patients with lumbar spinal canal stenosis. Spine (Phila Pa 1976) (2007) 1.18
Skeletal muscle gene expression in space-flown rats. FASEB J (2004) 1.18
The a3 isoform vacuolar type H⁺-ATPase promotes distant metastasis in the mouse B16 melanoma cells. Mol Cancer Res (2011) 1.17
Phenotypic characterization of early onset Paget's disease of bone caused by a 27-bp duplication in the TNFRSF11A gene. J Bone Miner Res (2003) 1.14
Contribution of genetic factors to the pathogenesis of Paget's disease of bone and related disorders. J Bone Miner Res (2006) 1.14
Influence of LRP5 polymorphisms on normal variation in BMD. J Bone Miner Res (2004) 1.14
Transforming growth factor-beta 1 mutations in Camurati-Engelmann disease lead to increased signaling by altering either activation or secretion of the mutant protein. J Biol Chem (2002) 1.13
SNPs in the KCNJ11-ABCC8 gene locus are associated with type 2 diabetes and blood pressure levels in the Japanese population. J Hum Genet (2007) 1.12
A point mutation in the ubiquitin-associated domain of SQSMT1 is sufficient to cause a Paget's disease-like disorder in mice. Hum Mol Genet (2011) 1.12
Pharmacologic inhibitors of IkappaB kinase suppress growth and migration of mammary carcinosarcoma cells in vitro and prevent osteolytic bone metastasis in vivo. Mol Cancer Ther (2009) 1.12
Osteoactivin upregulates expression of MMP-3 and MMP-9 in fibroblasts infiltrated into denervated skeletal muscle in mice. Am J Physiol Cell Physiol (2005) 1.10
Genotype-phenotype relationship in human ATP6i-dependent autosomal recessive osteopetrosis. Am J Pathol (2003) 1.09
Novel UBA domain mutations of SQSTM1 in Paget's disease of bone: genotype phenotype correlation, functional analysis, and structural consequences. J Bone Miner Res (2004) 1.09
Osteoporosis associated with neutralizing autoantibodies against osteoprotegerin. N Engl J Med (2009) 1.08
Incidence and etiology of lumbar spondylolysis: review of the literature. J Orthop Sci (2010) 1.07
Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: the GENOMOS study. Bone (2007) 1.07
Mice lacking the EDB segment of fibronectin develop normally but exhibit reduced cell growth and fibronectin matrix assembly in vitro. Cancer Res (2002) 1.07
Technical and clinical characterization of the Bio-PTH (1-84) immunochemiluminometric assay and comparison with a second-generation assay for parathyroid hormone. Clin Chem (2003) 1.05
The TRPV1 ion channel antagonist capsazepine inhibits osteoclast and osteoblast differentiation in vitro and ovariectomy induced bone loss in vivo. Bone (2010) 1.04
Cannabinoid receptor type 1 protects against age-related osteoporosis by regulating osteoblast and adipocyte differentiation in marrow stromal cells. Cell Metab (2009) 1.04
Association between decreased bone mineral density and severity of distal radial fractures. J Bone Joint Surg Am (2009) 1.04
Guidelines for diagnosis and management of Paget's disease of bone in Japan. J Bone Miner Metab (2006) 1.04
Replication of reported genetic associations of PADI4, FCRL3, SLC22A4 and RUNX1 genes with rheumatoid arthritis: results of an independent Japanese population and evidence from meta-analysis of East Asian studies. J Hum Genet (2007) 1.04
Regulation of bone mass and bone turnover by neuronal nitric oxide synthase. Endocrinology (2004) 1.03
Regulation of bone mass, osteoclast function, and ovariectomy-induced bone loss by the type 2 cannabinoid receptor. Endocrinology (2008) 1.02
Recent insights into the pathogenesis of hyperuricaemia and gout. Hum Mol Genet (2009) 1.02
Multicenter evaluation of a new immunoassay for intact PTH measurement on the Elecsys System 2010 and 1010. Clin Lab (2002) 1.01
Sp1 family of transcription factors regulates the human alpha2 (XI) collagen gene (COL11A2) in Saos-2 osteoblastic cells. J Bone Miner Res (2006) 1.01
Hematoma in the cervical ligamentum flavum. Report of a case and review of the literature. Skeletal Radiol (2009) 1.01
MRI signal changes of the pedicle as an indicator for early diagnosis of spondylolysis in children and adolescents: a clinical and biomechanical study. Spine (Phila Pa 1976) (2006) 1.01
Conservative treatment for pediatric lumbar spondylolysis to achieve bone healing using a hard brace: what type and how long?: Clinical article. J Neurosurg Spine (2012) 1.01
Assessment of osteoarthritis candidate genes in a meta-analysis of nine genome-wide association studies. Arthritis Rheumatol (2014) 1.00
Three successive stress fractures at the same vertebral level in an adolescent baseball player. Am J Sports Med (2003) 1.00
Promoter and intron 1 polymorphisms of COL1A1 interact to regulate transcription and susceptibility to osteoporosis. Hum Mol Genet (2009) 0.99
Ubiquitin ligase gene expression in healthy volunteers with 20-day bedrest. Muscle Nerve (2006) 0.98
Effect and safety of intermittent weekly administration of human parathyroid hormone 1-34 in patients with primary osteoporosis evaluated by histomorphometry and microstructural analysis of iliac trabecular bone before and after 1 year of treatment. J Bone Miner Metab (2004) 0.97
A novel type of EWS-CHOP fusion gene in myxoid liposarcoma. Biochem Biophys Res Commun (2006) 0.95
Identification of a major locus for Paget's disease on chromosome 10p13 in families of British descent. J Bone Miner Res (2008) 0.94
Linkage disequilibrium between polymorphisms in the human TNFRSF1B gene and their association with bone mass in perimenopausal women. Hum Mol Genet (2002) 0.93
Subchondral cysts in dysplastic osteoarthritic hips communicate with the joint space: analysis using three-dimensional computed tomography. Eur J Orthop Surg Traumatol (2012) 0.93
Prevalence and clinical features of Paget's disease of bone in Japan. J Bone Miner Metab (2006) 0.93
Minimally invasive technique for direct repair of pars interarticularis defects in adults using a percutaneous pedicle screw and hook-rod system. J Neurosurg Spine (2009) 0.93
Cannabinoids and bone: friend or foe? Calcif Tissue Int (2010) 0.92
The type 2 cannabinoid receptor regulates bone mass and ovariectomy-induced bone loss by affecting osteoblast differentiation and bone formation. Endocrinology (2011) 0.92
Small molecule inhibitors of IkappaB kinase signaling inhibit osteoclast formation in vitro and prevent ovariectomy-induced bone loss in vivo. FASEB J (2010) 0.91
Intramedullary schwannoma with calcification of the epiconus. Spine J (2009) 0.91
Overexpression of HMGA2-LPP fusion transcripts promotes expression of the alpha 2 type XI collagen gene. Biochem Biophys Res Commun (2005) 0.91
Conservative treatment for osteochondrosis of the humeral capitellum. Am J Sports Med (2008) 0.90
The pro and con of measles virus in Paget's disease: con. J Bone Miner Res (2002) 0.90
Mechanisms of disease: genetics of Paget's disease of bone and related disorders. Nat Clin Pract Rheumatol (2006) 0.90
Association of single-nucleotide polymorphisms in the suppressor of cytokine signaling 2 (SOCS2) gene with type 2 diabetes in the Japanese. Genomics (2006) 0.90
Intrafamilial phenotypic diversity in multiple epiphyseal dysplasia associated with a COL9A2 mutation (EDM2). Clin Rheumatol (2006) 0.90
Correction of deformity and shortening due to post traumatic epiphyseal arrest by distraction osteogenesis. Arch Orthop Trauma Surg (2007) 0.90
Distinct expression of mast cell tryptase and protease activated receptor-2 in synovia of rheumatoid arthritis and osteoarthritis. Clin Rheumatol (2007) 0.90
Newly occurred L4 spondylolysis in the lumbar spine with pre-existence L5 spondylolysis among sports players: case reports and biomechanical analysis. Arch Orthop Trauma Surg (2008) 0.89
Common susceptibility alleles and SQSTM1 mutations predict disease extent and severity in a multinational study of patients with Paget's disease. J Bone Miner Res (2013) 0.89
Interspecies synteny mapping identifies a quantitative trait locus for bone mineral density on human chromosome Xp22. Hum Mol Genet (2005) 0.89
Continuous infusion of insulin-like growth factor-I into the epiphysis of the tibia. Int Orthop (2007) 0.89
Association between single-nucleotide polymorphisms in the SEC8L1 gene, which encodes a subunit of the exocyst complex, and rheumatoid arthritis in a Japanese population. Arthritis Rheum (2005) 0.89
Adolescents with symptomatic laminolysis: report of two cases. J Orthop Traumatol (2010) 0.89
Mutations of SQSTM1 are associated with severity and clinical outcome in paget disease of bone. J Bone Miner Res (2010) 0.89
LRP5 Polymorphisms and response to risedronate treatment in osteoporotic men. Calcif Tissue Int (2009) 0.88